CN Patent

CN117586372A — 一种长效特立帕肽化合物

Assigned to Chengdu Aoda Biotechnology Co Ltd · Expires 2024-02-23 · 2y expired

What this patent protects

本发明涉及医药合成领域，公开了一种长效特立帕肽化合物。本发明所述一种长效化合物用于制备治疗疾病的药物组合物，所述药物组合物在预防和治疗骨质疏松症中的应用。

USPTO Abstract

本发明涉及医药合成领域，公开了一种长效特立帕肽化合物。本发明所述一种长效化合物用于制备治疗疾病的药物组合物，所述药物组合物在预防和治疗骨质疏松症中的应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN117586372A
Jurisdiction
CN
Classification
—
Expires
2024-02-23
Drug substance claim
No
Drug product claim
No
Assignee
Chengdu Aoda Biotechnology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.